Trends in the treatment of cutaneous T-cell lymphoma – critical evaluation and perspectives on vorinostat
Sophia Rangwala, Madeleine Duvic, Chunlei ZhangDepartment of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USAAbstract: Epigenetic modification with small molecule histone deacetylase inhibitors has been a promising new anti-neoplastic approach for various solid and...
Saved in:
Main Authors: | Zhang CL, Duvic M, Rangwala S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/a3c1e6d15fda411cb1a406a59d3ef5d8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
by: Bodiford A, et al.
Published: (2015) -
Reduced intensity treatment in early-stage Hodgkin’s lymphoma
by: Armitage JO, et al.
Published: (2011) -
mTOR inhibitor in the treatment of Hodgkin’s lymphoma: a case report
by: Provencio M., et al.
Published: (2011) -
First-line therapy of chronic myeloid leukemia – focus on dasatinib
by: Amrein PC
Published: (2012) -
Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase
by: Farina F, et al.
Published: (2014)